MesoSilver (Colloidal Silver)

MesoSilver (Colloidal Silver Nanoparticles)

Unleashing the Untapped Potential of Silver Nanoparticles in Cancer Treatment

Throughout history, silver has been celebrated for its antimicrobial properties. Ancient Romans harnessed silver for water purification, and it is believed that silver nitrate was used medicinally as far back as 69 B.C.E. Persian kings, including Cyrus, were known to drink water stored in silver containers to keep it fresh for years.

In recent decades, scientific studies have demonstrated that silver, particularly in the form of nanoparticles, possesses antibacterial, antifungal, and antiviral properties, targeting a wide range of pathogens. As a result, silver nanoparticles have found applications in medical care, such as antibacterial wound dressings for burn patients, and researchers have even considered developing techniques to coat glass with a layer of silver ions to prevent the growth of pathogenic bacteria.

The exact mechanism of how colloidal silver works is still being debated, but it is believed to join onto proteins in bacterial cell walls, causing harm to the membranes and eventually killing the bacteria. Colloidal silver is believed to have the ability to destroy methicillin-resistant Staphylococcus aureus (MRSA), a deadly flesh-eating superbug. Research conducted in the 1970s by Robert O. Becker, M.D. at Syracuse University, discovered the antibacterial properties of electrically generated silver ions against antibiotic-resistant pathogens. Despite the FDA's attempts to discredit Becker's findings, recent clinical studies have confirmed that silver is the top agent in fighting MRSA and other deadly pathogens. The FDA has limited control over private and foreign universities' medical research departments, and studies conducted by these institutions have proven silver's ability to kill MRSA. Some studies claim it can treat conditions such as Lyme disease, tuberculosis, HIV, and cancer.

Excitingly, silver nanoparticles have also demonstrated anticancer potential. Laboratory experiments have shown that these particles, when used alone or in combination with conventional therapies like chemotherapy and radiotherapy, can kill various cancer cells, including pancreatic, cervical, ovarian, breast, glioma, lung, leukemia, lymphoma, and hepatocellular carcinoma. Due to their mechanism of action, silver nanoparticles are expected to be effective against most types of cancer, both directly and indirectly, by inhibiting the formation of new blood vessels and killing intratumoral bacteria.

Intratumoral bacteria play a significant role in cancer treatment resistance. Tumor tissues often experience hypoxia and necrosis due to rapid growth, creating an environment conducive to bacterial colonization. Studies published in leading journals, Nature and Science, have shown that tumor colonization by bacteria can significantly increase resistance to chemotherapy. This research suggests that antibacterial treatments, such as silver solutions, should be used before, during, and after conventional treatments to improve treatment outcomes.

In addition to laboratory evidence and anecdotal reports, scientific case studies have demonstrated the potential of silver nanoparticles in cancer treatment. One such case involved a 78-year-old man whose aggressive cancer did not respond to conventional treatment. After using a silver nanoparticle solution for three months, the patient experienced significant clinical improvements and complete disappearance of all metastases. The patient's recovery persisted for 36 months and is ongoing.

Considering the accessibility, low cost, ease of implementation, and established safety profile of silver nanoparticles, they are a promising option for cancer patients with limited treatment options. While silver nanoparticles should not be used as a standalone treatment, they can be integrated into a comprehensive treatment strategy, alongside conventional or alternative treatments.

The various anticancer mechanisms of silver nanoparticles include:

1. ROS generation: Triggering mitochondria-mediated apoptosis by increasing ROS production and decreasing ATP generation (Ref.).
2. Anti-angiogenesis: Inhibiting the formation of new blood vessels by modulating copper metabolism and HIF-1. 3. Autophagy disruption.
3. Killing intratumoral bacteria.
4. Multi Drug Resistance (MDR1) inhibition: Enhancing the effectiveness of chemotherapy.
5. Inducing endoplasmic reticulum (ER) stress.

When selecting a source of silver nanoparticles, it is crucial to ensure only the best. Out of all colloidal silver products, Mesosilver is considered the best due to its high particle content (over 80%) and particle size of 0.65 nm at 20 ppm. It is also manufactured in a highly controlled facility, approved by the FDA, ensuring its quality and safety for public use. It's important to keep in mind that there are no specific regulations for colloidal silver, but all manufacturing facilities are monitored by the FDA, just like any other food or pharmaceutical product.

All test carried out by Purest Colloids show that Mesosilver™ is completely safe. One research document states that silver is effective against 650 strains of microorganisms.

In conclusion, the time-tested antimicrobial properties of silver, combined with emerging evidence of its anti-cancer potential, make it a promising option for cancer patients, particularly when incorporated into a comprehensive treatment plan. Before taking any dietary supplement or using alternative medicine, it's always best to speak with a healthcare provider.

References:

1. https://pubmed.ncbi.nlm.nih.gov/30483817/
2. https://pubmed.ncbi.nlm.nih.gov/27574420/
3. https://pubmed.ncbi.nlm.nih.gov/31019258/
4. https://pubmed.ncbi.nlm.nih.gov/30135366/
5. https://pubmed.ncbi.nlm.nih.gov/23785037/
6. https://pubmed.ncbi.nlm.nih.gov/18505176/
7. https://pubmed.ncbi.nlm.nih.gov/31051440/
8. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2818642/
9. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6264685/
10. https://pubmed.ncbi.nlm.nih.gov/29435134/
11. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5797005/
12. https://pubmed.ncbi.nlm.nih.gov/28919753/
13. https://pubmed.ncbi.nlm.nih.gov/27536105/
14. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3558162/
15. https://pubmed.ncbi.nlm.nih.gov/30670028/
16. https://pubmed.ncbi.nlm.nih.gov/27757033/
17. https://pubmed.ncbi.nlm.nih.gov/26867977/
18. https://analyticalsciencejournals.onlinelibrary.wiley.com/doi/abs/10.1002/jat.2957
19. https://pubmed.ncbi.nlm.nih.gov/21042421/
20. https://pubmed.ncbi.nlm.nih.gov/30274079/
21. https://pubmed.ncbi.nlm.nih.gov/19508889/
22. https://pubmed.ncbi.nlm.nih.gov/21042421/
23. https://www.ingentaconnect.com/content/asp/jbn/2008/00000004/00000002/art00003;jsessionid=1gto15xi29eyc.x-ic-live-03
24. https://www.dovepress.com/silver-nanoparticles-induce-reactive-oxygen-species-mediated-cell-cycl-peer-reviewed-fulltext-article-IJN

25. https://www.news-medical.net/news/20191106/Differences-between-colloidal-silver-and-ionic-silver-solutions.aspx

26. https://pdfs.semanticscholar.org/2563/2ce5144503bfb5964b34eda6feea396bf449.pdf?_ga=2.174400162.1248551559.1562605712-1281643156.1562605712